Page last updated: 2024-08-24

oseltamivir and organophosphonates

oseltamivir has been researched along with organophosphonates in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keating, MR1
Cheng, YS; Fang, JM; Hsiao, SC; Shie, JJ; Su, CY; Tsai, KC; Wang, SY; Wong, CH; Yang, AS1
Callum, L; Carbain, B; Collins, PJ; Hay, AJ; Martin, SR; McCauley, J; Streicher, H1
Bren, U; Frecer, V; Rungrotmongkol, T; Stanislav, M; Udommaneethanakit, T1
Razonable, RR1
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH1

Reviews

3 review(s) available for oseltamivir and organophosphonates

ArticleYear
Antiviral agents for non-human immunodeficiency virus infections.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir

1999
Antiviral drugs for viruses other than human immunodeficiency virus.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir

2011
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 67

    Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases

2016

Other Studies

3 other study(ies) available for oseltamivir and organophosphonates

ArticleYear
Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Journal of the American Chemical Society, 2007, Oct-03, Volume: 129, Issue:39

    Topics: Animals; Antiviral Agents; Cell Line; Dogs; Enzyme Inhibitors; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Kinetics; Models, Molecular; Neuraminidase; Organophosphonates; Oseltamivir

2007
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.
    ChemMedChem, 2009, Volume: 4, Issue:3

    Topics: Antiviral Agents; Humans; Influenza A virus; Neuraminidase; Organophosphonates; Oseltamivir

2009
Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Journal of chemical information and modeling, 2009, Volume: 49, Issue:10

    Topics: Acids, Carbocyclic; Animals; Antiviral Agents; Cyclopentanes; Drug Design; Enzyme Inhibitors; Guanidines; Influenza A Virus, H5N1 Subtype; Molecular Conformation; Molecular Dynamics Simulation; Neuraminidase; Organophosphonates; Oseltamivir; Time Factors; Zanamivir

2009